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Brief Communications
Specific Drosophila Dscam Juxtamembrane Variants Control
Dendritic Elaboration and Axonal Arborization
Lei Shi,* Hung-Hsiang Yu,* Jacob S. Yang,* and Tzumin Lee
Department of Neurobiology, University of Massachusetts Medical School, Worcester, Massachusetts 01605
DrosophilaDscam isoforms are derived from two alternative transmembrane/juxtamembrane domains (TMs) in addition to thousands
of ectodomainvariants.Using amicroRNA-basedRNA interference technology,we selectively knockeddowndifferent subsets ofDscams
containing either the exon 17.1- or exon 17.2-encoding TM. Eliminating Dscam[TM1] reduced Dscam expression butminimally affected
postembryonic axonal morphogenesis. In contrast, depleting Dscam[TM2] blocked axon arborization. Further removal of Dscam[TM1]
enhanced the loss-of-Dscam[TM2] axonal phenotypes. However, Dscam[TM1] primarily regulates dendritic development, as evidenced
by the observations that removing Dscam[TM1] alone impeded elaboration of dendrites and that transgenic Dscam[TM1], but not
Dscam[TM2], effectively rescued Dscam mutant dendritic phenotypes in mosaic organisms. These distinct Dscam functions can be
attributed to the juxtamembrane regions of TMs that governdendritic versus axonal targeting ofDscamaswell. Together,we suggest that
specific Drosophila Dscam juxtamembrane variants control dendritic elaboration and axonal arborization.
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Introduction
The insect Dscam gene encodes thousands of distinct
immunoglobulin/fibronectin-type cell adhesion molecules that
mainly differ in their extracellular domain and can carry one of
the two well-conserved transmembrane/juxtamembrane seg-
ments (TMs) (Schmucker et al., 2000). The variations in the
ectodomain have drastic impacts on the inter-Dscam binding in
vitro (Wojtowicz et al., 2004), whereas distinct TMs may target
Dscam to different subcellular compartments (Wang et al., 2004;
Zhan et al., 2004). Such a huge repertoire of diverse homophilic
cell adhesionmolecules may help govern how a complex nervous
system is specifically wired.
In Drosophila, Dscam is widely required for proper neuronal
morphogenesis, especially the bifurcation/arborization of neu-
rites. Interestingly, loss of Dscam function affects neurite trajec-
tories selectively at the loci where bifurcation normally occurs
(Wang et al., 2002; Chen et al., 2006). Some Dscammutant neu-
rites stall with clumps of possibly numerous short branches at the
ends, resulting in truncation of axonal trees at their first points of
bifurcation. These characteristic phenotypes are probably de-
rived from excessive repetitive bifurcations of mutant growth
cones, because others that have fully extended frequently exhibit
evidence for additional bifurcations at the normal branching
points. In addition, proper guidance of individual growth cones
at the points of ramification, especially with respect to their sister
growth cones, requires Dscam. It appears that Dscam controls
neurite arborization by preventing comigration of sister growth
cones, thus preventing the number of sister growth cones from
exceeding the number of available fascicles. Dynamic stochastic
expression of distinct Dscam ectodomains (Neves et al., 2004)
would permit self recognition in such “like-kill-like” morphoge-
netic processes. Consistent with this model, most Dscam ectodo-
main exon alternatives are not conserved through evolution, ar-
guing that the overall diversity is more critical than the identities
of individual variants (Graveley et al., 2004).
In contrast, the two exon alternatives that encode the TM of
Dscam are well conserved (Graveley et al., 2004). Interestingly,
ectopic Dscam can be preferentially localized to dendrites by se-
lective utilization of exon 17.1 (encoding TM1) or localized to
axons by using exon 17.2 (encoding TM2) (Wang et al., 2004). To
determine the roles of Dscam[TM1] versus Dscam[TM2], we
previously created Dscams lacking either exon 17.1 or exon 17.2.
Deletion of either exon 17 led to skipping of the other exon 17 in
manyDscam transcripts (our unpublished results).Manipulating
genomic Dscam can be problematic for other reasons (see Dis-
cussion). We, thus, resorted to a microRNA(miRNA)-based
RNA interference (RNAi) technology (Chen et al., 2007) for spe-
cifically silencing exon 17.1- or exon 17.2-containing Dscam
transcripts. We found that endogenous Dscam[TM1] and
Dscam[TM2] primarily act to mediate dendritic elaboration and
axonal arborization, respectively. Consistent results were ob-
tained with transgenic Dscam alleviating dendrite versus axon
phenotypes in Dscammutant clones depending on the nature of
its TM. In addition, the cytoplasmic juxtamembrane regions of
the TMs are sufficient to control Dscam localization as well as its
differential roles in dendrites versus axons. Together, we suggest
that Dscams with distinct TMs control dendritic elaboration ver-
sus axonal arborization.
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Materials andMethods
Transgenes. Standard molecular biological techniques were used to gen-
erate UAS-17.1 miRNA, UAS-17.2 miRNA, and UAS-18 miRNA, which
encodemicroRNAs carrying uniqueDscam sequences derived from exon
17.1, exon 17.2, and exon 18, respectively. The complete nucleotide se-
quences of the microRNA constructs are available on request. In addi-
tion, the details about how the twoUAS-Dscamswith chimeric TMswere
constructed are available on request.
Flies. Transgenic flies carrying various UAS-miRNA and UAS-Dscam
with chimeric TMwere obtained by P element-mediated germ line trans-
formation with technical support from Genetic Services.
Tissue-specific induction of RNAi and phenotypic analysis by immuno-
histochemistry. Targeted induction of UAS-miRNA involved use of vari-
ous tissue-specific galactosidase-4 (GAL4) drivers, and their phenotypic
analysis mainly involved coexpression of various upstream activation
sequence (UAS)-reporter genes. Both flip-out-marked clones of ellipsoid
body (EB) neurons andMARCM (mosaic analysis with a repressible cell
marker)-labeled clones of projection neurons (PNs) were induced in
newly hatched larvae by heat shock for 40 min at 37°C. Whole fly brains
were prepared for immunostaining as described previously (Lee et al.,
1999). Detection of endogenous Dscam proteins involved a mouse
monoclonal antibody (mAb) that was raised against the peptide ATLD-
KRRPDLRDELG. The anti-Dscam mAb, 1D4 mAb, and anti-mCD8
mAbwere used at 1:20, 1:50, and 1:100, respectively. Fluorescence signals
were captured with confocal microscopy and processed using Adobe
Photoshop (Adobe Systems, San Jose, CA).
Results
microRNA-based RNA interference permits selective
depletion of Dscam[TM1] versus Dscam[TM2]
TransgenicDrosophilaDscams with distinct TMs are enriched in
dendrites or axons (Wang et al., 2004) and, consistent with such
differential protein targeting phenomena, potently affect differ-
ent aspects of neuronal morphogenesis (Wang et al., 2004; Zhan
et al., 2004). To determine whether endogenous Dscam with
TM1 versus TM2 indeed helps govern different neuronal mor-
phogenetic processes, we examined whether and how targeted
depletion of Dscam[TM1] or Dscam[TM2] perturbs distinct as-
pects of neuronal morphogenesis in intactDrosophila brains. We
first explored whether one can effectively knock down
Dscam[TM1] versus Dscam[TM2] by specifically silencing the
Dscam transcripts that carry exon 17.1 or exon 17.2 using a
miRNA-based RNAi technology (Chen et al., 2007). We engi-
neered three UAS-miRNA constructs, UAS-17.1 miRNA, UAS-
17.2miRNA, andUAS-18miRNA, to specifically target theDscam
exon 17.1, exon 17.2, and exon 18 (a common Dscam exon),
respectively. For each UAS-miRNA transgene, we identified the
most potent transgenic line frommultiple independent transfor-
mants by individually assaying its ability to antagonize GAL4-
induced coexpression of UAS-Dscam::GFP (green fluorescent
protein). We resorted to transgenic Dscam::GFP, because direct
visualization of Dscam[TM1] versus Dscam[TM2] was not pos-
sible without antibodies against different TMs. Pairing transgenic
miRNA with Dscam::GFP that carries the miRNA target se-
quences consistently led to a drastic reduction in the level of
Dscam-GFP expression (Fig. S1C,F, available at www.jneuro-
sci.org as supplemental material). In contrast, even with themost
potent transgenic line, UAS-17.1 miRNA and UAS-17.2 miRNA
exerted no detectable effect on the alternative isoform (Fig.
S1D,E, available at www.jneurosci.org as supplemental mate-
rial). It assures no cross-reactivity, also eliminating the trivial
explanation that suppression of Dscam transgenes might result
from the presence of multiple UAS transgenes. These observa-
tions provide us with the opportunity to use transgenic miRNA
to knock down specific subsets of Dscam isoforms in intact fly
brains.
We then examined how a broad induction of various Dscam-
targeted miRNAs affects the endogenous Dscam expression in
the developingDrosophilaCNS.We could normally detect abun-
dant Dscam proteins in the larval neuropils by immunostaining
with a peptide antibody against some Dscam common motif(s)
(Wang et al., 2004) (Fig. 1A). Interestingly, such Dscam immu-
noreactivity was differentially abolished after pan-neuronal in-
duction of variousmiRNA transgenes. First, we were encouraged
by the lack of detectable residual Dscam after induction of
UAS-18 miRNA (Fig. 1B) or coinduction of UAS-17.1 miRNA
and UAS-17.2 miRNA (Fig. 1C), which are both expected to si-
lence all Dscam splice variants. Second, induction of UAS-17.1
miRNA or UAS-17.2 miRNA alone, even in multiple copies, left
its overall pattern of expression essentially unchanged (Fig.
1D,E).DepletingDscam[TM1] versusDscam[TM2] should pro-
vide insight into the spatial/temporal patterns of TM1 versus
TM2 expression. Interestingly, close inspection revealed that
Dscam[TM1] apparently exists more abundantly than
Dscam[TM2] in the larval CNS, especially within the abdominal
ganglion (Fig. 1, compareDwithE). Together, these observations
demonstrate the general feasibility of knocking down
Dscam[TM1] versus Dscam[TM2] using UAS-17.1 miRNA or
UAS-17.2 miRNA. Additionally, both UAS-18 miRNA alone and
UAS-17.1 miRNA plus UAS-17.2 miRNA should allow us to de-
termine theDscam“null” phenotypes one can obtainwith various
GAL4 drivers.
Figure 1. Silencing of endogenous Dscam expression by various transgenic miRNAs. Composite confocal images of wandering larvae CNS showing endogenous Dscam expression (magenta; as
revealed by immunostaining with an anti-Dscam exon 18 peptide mAb), in wild-type (WT) and after asense-GAL4/GAL4-C155-dependent induction of various anti-Dscam miRNAs (B–E). A,
Wild-type control. Note that UAS-18 miRNA alone (B) or only UAS-17.1 miRNA plus UAS-17.2 miRNA (C) could effectively eliminate the entire Dscam expression. In addition, regardless of the levels
of Dscam, major neural structures, as revealed by coinduction of UAS-mCD8::GFP (green), remained comparable (insets). Scale bar: (here and in all figures) 20m.
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Dscam[TM2], but not Dscam[TM1], plays an essential role in
governing axon arborization, probably because of differential
protein targeting
To determine the roles of Dscam[TM1] versus Dscam[TM2] in
Dscam-dependent axonal morphogenesis, we first examined
how expression of specific Dscam-targeted miRNAs affects the
morphogenesis of mushroom body (MB) axons. Transgenic
miRNA was induced through MB development using GAL4-
OK107. We selectively focused on its effects on the orthogonal 
and  lobes, because they are normally derived via Dscam-
governed axon bifurcation, and one can readily identify the MB
/ axons based on their strong immunoreactivity with the 1D4
monoclonal antibody (Wang et al., 2002). Interestingly, induc-
tion ofUAS-18 miRNA orUAS-17.2 miRNA alone, but notUAS-
17.1 miRNA, drastically disrupted the formation of / lobes
(Fig. 2). Abnormal / lobes were often misshapen and variably
truncated (Fig. 2B–E), reminiscent of the deformed MBs in
Dscam mutant organisms (Wang et al., 2004). This suggests in-
volvement of Dscam[TM2], but not Dscam[TM1], inMB axonal
morphogenesis. We further classified the anomalies based on the
presence or absence of any / lobe residue and its degree of
extension (severe, no / neurite ex-
tended beyond the peduncle terminus;
strong, no neurite reached the tips of /
lobes; medium, small subsets of / neu-
rites were fully extended; weak, grossly in-
tact lobes failed to segregate). Quantitative
analysis of the above phenotypes (n 100,
each) revealed that UAS-17.2 miRNA
alone did not cause as much of a defect as
UAS-18 miRNA (Fig. 2 I) (5.0  2.0 vs
52.7  4.5% for the severe phenotype).
This is apparently a result of the possibility
that endogenous Dscam[TM1] could
partially compensate for the loss of
Dscam[TM2] in the Dscam-governed bi-
furcation of MB axons, because doubling
the dosage of UAS-17.2 miRNA did not
enhance the phenotypes (8.7 2.5%), but
coinduction of UAS-17.1 miRNA and
UAS-17.2 miRNA fully recapitulated the
18 miRNA-derived null phenotypes
(59.0  6.0%) (Fig. 2 I). Together, these
results provide direct evidence for differ-
ential involvement of Dscam[TM1] and
Dscam[TM2] in supporting neuronal
morphogenesis.
Preferential usage of exon 17.2 over exon
17.1 might explain why Dscam[TM2] plays
a dominant role in this particular develop-
mental event. To rule out this possibility, we
attempted to rescue the 18 miRNA-derived
null phenotypes by supplementing trans-
genic Dscam[TM1] or Dscam[TM2]. We
reasoned that both Dscam transgenes carry
wild-type exon 18 and should be sup-
pressed by 18 miRNA to an analogous de-
gree, if they were comparably induced.
Additionally, their ability to antagonize si-
lencing of endogenous Dscam by 18
miRNA should be identical. Thus, any dif-
ference in their rescue of 18 miRNA-
derived loss-of-Dscam phenotypes can
be ascribed to the presence of TM1 or TM2 in the comparably
residual transgenic Dscam. We previously identified
UAS-Dscam::GFPs that exhibit similar levels of induction (Wang
et al., 2004). Using these lines, we obtained substantially better
rescue after coinduction of UAS-18 miRNA with UAS-
Dscam[exon 17.2]::GFP than with UAS-Dscam[exon 17.1]::GFP
(Fig. 2 I) (38.0  1.8 vs 6.9  0.4% for the weak plus normal
phenotypes). This supports the notion that Dscam[TM2] and
Dscam[TM1], which differ only in the TMs, are functionally dis-
tinct. To locate the structural basis for such a functional distinc-
tion between Dscam[TM1] and Dscam[TM2], we conducted
structural-functional analysis and generated two chimeric TMs
by swapping the cytoplasmic juxtamembrane portions between
TM1 andTM2 (Fig. 2F). Interestingly, this exchange reversed the
functional distinction (Fig. 2 I) (rescued to 69.0  3.0% with
17.1/17.2 vs 7.3 2.4%with 17.2/17.1) aswell as their differential
protein targeting between Dscam[TM1] and Dscam[TM2] (Fig.
2G,H). These results suggest that the cytoplasmic juxtamem-
brane domains of Dscam govern its TM-dependent differential
subcellular localization and further imply that, probably because
of differential targeting, TM2-containing Dscam isoforms func-
Figure 2. Dscam[TM2], but not Dscam[TM1], plays an essential role in MB axonal morphogenesis. A–E, Adult MB lobes
visualized by 1D4mAb. Comparedwith thewild type (A), induction of certain anti-DscammiRNAs (see I ) disrupted the formation
ofMB/ lobes to various extents (B–E).F–H, Derivationof two chimeric DscamTMs (F ) and their effects onDscam::GFP (green)
protein targeting. After binary induction with GAL4–201Y, Dscam[17.1/17.2]::GFP, like Dscam[TM2]::GFP, is uniformly distrib-
uted in the larval MBs (G). In contrast, Dscam[17.2/17.1]::GFP, like Dscam[TM1]::GFP, is enriched in dendrites (H ). Additionally,
both Dscam[17.1/17.2]::GFP andDscam[TM2]::GFP are preferentially targeted to axons after suppression of the induction by RNAi
(data not shown) (similar to Fig. S1 F,H, available at www.jneurosci.org as supplemental material). I, Quantitative analysis of MB
lobe phenotypes, based on the above classification (A–E), after GAL4-OK107-dependent induction of various anti-DscammiRNAs
and in the absence or presence of distinct transgenic Dscam::GFP.
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tion primarily in axons, whereas TM1-
containing Dscams possibly act in den-
drites within neurons.
To examine whether Dscam[TM2],
but not Dscam[TM1], is broadly used to
mediate diverse axonal morphogenesis,
we further investigated whether and how
knocking down Dscam[TM1] or
Dscam[TM2] levels affects the morpho-
genesis of EB neurons.We reported previ-
ously that Dscam-dependent proper ar-
borization of axons is also required for full
elaboration of EB neurites in the centrally
placed EB neuropil (Wang et al., 2002).
Interestingly, after separate induction of
UAS-17.1 miRNA and UAS-17.2 miRNA
using asense-GAL4 (Zhu et al., 2006b) plus
GAL4-EB1 (Wang et al., 2002), onlyUAS-
17.2 miRNA could phenocopy the mor-
phogenetic defects characteristic ofDscam
mutant EBneurons (Fig. S2A–D, available
at www.jneurosci.org as supplemental
material) (100%; n  10, each). This ob-
servation again supports the notion that
Dscam[TM2], but not Dscam[TM1],
plays an essential role in governing diverse axonalmorphogenetic
processes, and, as addressed above, this difference in function is
probably derived from differential protein targeting.
Dscam[TM1] is involved primarily in dendritic elaboration
Transgenic Dscam[TM1]::GFP is selectively enriched in den-
drites in diversemodel neurons, including the antennal lobe (AL)
PNs (Wang et al., 2004). To determine whether Dscam[TM1] is
preferentially involved in dendritic morphogenesis, we resorted
to PNs for additional analysis of the TM-dependent distinct
Dscam morphogenetic functions. In contrast with MB and EB
neurons where Dscam appears dispensable for dendritic mor-
phogenesis (Wang et al., 2002), the PNs, especially the ventral
lineage-derived multiglomeruli-targeting PNs (in the vPN
clones), require Dscam for full elaboration of their dendrites in
the ALs in addition to proper arborization of their axons in the
lateral horns (LHs) (Zhu et al., 2006a).
We first demonstrated that GAL4-GH146-dependent induc-
tion of UAS-18 miRNA in the otherwise wild-type vPN neuro-
blast (Nb) clones potently suppressed the elaboration of
MARCM-labeled dendrites in the ALs and disrupted their axonal
arborization in the LHs (Fig. 3D,H,L) (100%; n 10). The den-
drites of multiglomeruli-targeting PNs became aberrantly re-
stricted to the AL medial upper portion where the axon passage
resides (Fig. 3H, arrow). In the LHs, their axonal branches failed
to extend away fromone another and often stalledwith abnormal
aggregates (Fig. 3L, arrow). In addition, the projection out of the
LH (Fig. 3 I, J, arrowheads) is essentially missing. These mor
phogenetic defects are analogous to the previously documented
Dscam loss-of-function PN phenotypes (Zhu et al., 2006a).
We then wondered whether depleting Dscam[TM1] versus
Dscam[TM2] in the same neurons might differentially affect the
morphogenesis of their dendrites versus axons.UAS-17.1miRNA
and UAS-17.2 miRNA were separately induced by GAL4-GH146
in the vPN Nb clones. Remarkably, the loss-of-Dscam dendritic
and axonal phenotypes were uncoupled and well correlated with
the protein targeting phenomena. Induction ofUAS-17.1miRNA
alone effectively suppressed PN dendritic elaboration but mini-
mally affected their axonal arborization (Fig. 3B,F,J) (100%; n
9). In contrast, induction of UAS-17.2 miRNA alone selectively
disrupted the arborization of PN axons in the LHs (Fig. 3C,G,K)
(100%; n  15). We further quantified dendrite phenotypes by
counting the glomeruli that became not innervated by GAL4-
GH146-positive PNs in the above vPNNb clones. Given the pres-
ence of severalGAL4-GH146-positive pan-glomerular PNs in the
vPN lineage, there is normally no glomerulus where we could not
detect any vPN-lineage-derived GAL4-GH146-labeled neu-
rites. Such vPN dendrites were also fully elaborated after de-
pletion of endogenous Dscam[TM2], as revealed by no GAL4-
GH146-unlabeled glomerulus despite induction of 17.2
miRNA. In contrast, depleting endogenous Dscam[TM1] with
17.1 miRNAmade a significant and comparable number of AL
glomeruli devoid ofMARCM-labeled vPN dendrites as knock-
ing down all Dscam isoforms by 18miRNA (17.1, 10.86 0.69
vs 18, 11.00  0.82). These results collectively suggest that
differential protein targeting of Dscam[TM1] and
Dscam[TM2], respectively, controls dendritic elaboration and
axonal arborization.
Consistent with this notion, single-ectodomain transgenic
Dscam significantly rescued certainDscammutant phenotypes in
dendrites versus axons, depending on the presence of TM1 or
TM2. Briefly, using two distinctDscam transgenes that differ only
in their exon 17, we had shown previously that transgenic
Dscam[TM2], but not Dscam[TM1], could effectively rescue
various axonal morphogenetic defects in single-cell clones of
Dscam mutant MB neurons (Wang et al., 2004). Interestingly,
when the same pair ofDscam transgenes were respectively exam-
ined for its effects onDscammutant DL-1 PNs, we found that PN
dendrite defects were rescued only by transgenic Dscam[TM1],
whereas only transgenic Dscam[TM2] partially rescued PN bou-
ton formation in the MB calyces (Fig. 4). This provides RNAi-
independent evidence for involvement of Dscam[TM1] and
Dscam[TM2] in the morphogenesis of dendrites and axons,
respectively.
Figure 3. Dscam[TM1] and Dscam[TM2] primarily govern dendritic and axonal morphogenesis, respectively. MARCM-labeled
adult vPN Nb clones. Compared with the wild-type clone (A, green), induction of 17.1 miRNA, 17.2 miRNA, and 18 miRNA in vPN
Nb clones (B–D, green) specifically disrupted dendritic elaboration (F, arrow), axonal arborization (K, arrow), and both (H, L;
arrows), respectively. Adult fly brains were counterstained with nc82 mAb (magenta). The cropped images selectively show
dendritic elaboration (E–H ) or axonal arborization (I–L) of the clones.
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Discussion
Our use of an miRNA-based RNAi technology permits depletion
of distinct subsets of Dscam isoforms based on their exon com-
positions. Reducing TM1-containing (encoded by exon 17.1)
versus TM2-containing (encoded by exon 17.2) Dscams during
morphogenesis of various model neurons allowed us to demon-
strate that Dscam[TM1] and Dscam[TM2] are preferentially in-
volved in dendritic elaboration and axonal arborization, respec-
tively. This differential involvement of distinct Dscams is likely a
result of differential protein targeting, because they are specified
by similar cytoplasmic juxtamembrane portions of the Dscam
exon 17-encoding TMs. However, after strong binary induction,
transgenic Dscam[TM2] can exist abundantly in both dendrites
and axons, whereas Dscam[TM1] remains primarily restricted to
dendrites, although Dscam[TM1] exhibits more broad function
than Dscam[TM2]. Knocking down both further impeded MB
axons (Fig. 2 I), whereas eliminating exon 17.1-containingDscam
was equally potent as silencing all Dscam transcripts in the inhi-
bition of PN dendrites (Fig. 3). These discrepancies suggest tar-
geting-independent functional distinction between Dscam[TM1] and
Dscam[TM2].
Despite some recently raised concerns on the specificity of
RNAi-mediated gene silencing (Ma et al., 2006), we are confident
in this study for several reasons. First, it should be more straight-
forward to obviate potential off-target effects with the
microRNA-based RNAi constructs, because each of them only
yields two 22-nucleotide-long double-
stranded RNAs. Second, we generated an
independent miRNA-based RNAi con-
struct against a common Dscam exon in
addition to the ones targeting exon 17.1
versus exon 17.2 and have obtained the
expected results after analogous induction
of RNAi against these discrete Dscam se-
quences. Third, the specificity and effec-
tiveness of our RNAi was also confirmed
by direct visualization of specific Dscam
proteins in vivo. Fourth, all of our RNAi-
induced phenotypes were comparable
both qualitatively and quantitatively to
previously knownDscam loss-of-function
phenotypes. Fifth, we could also rescue the
RNAi-mediated silencing of Dscam using
appropriate Dscam transgenes. In addi-
tion, our demonstration that endogenous
Dscam mediates dendritic versus axonal
morphogenesis depending on the pres-
ence of TM1 or TM2 has been implicated
by multiple independent lines of research.
In particular, whereas transgenic Dscam
with TM2 consistently rescues of Dscam
mutant axons, Dscam[TM1] is much
more potent thanDscam[TM2] in the res-
cue of Dscam mutant dendrite
elaboration.
Alternative methods for knocking out
subsets of isoforms mainly involve dele-
tion of specific exon alternatives at the
genomic level. In theory, by gene targeting
(Gong and Golic, 2003), one can modify a
genomicDscam to carry only exon 17.1 or
exon 17.2 inDrosophila. But such genomic
manipulation is potentially problematic.
Assuming simple gene targeting does not alter the levels ofDscam
expression, elimination of subsets of isoforms could inevitably
lead to expression of other isoforms in much broader patterns
and/or at higher levels than the normal unperturbed conditions.
This may attenuate the defects resulting from the loss of specific
isoforms and/or elicit additional phenotypes because of ectopic
expression of the residual isoforms, further complicating inter-
pretation. In contrast, knocking down various subsets of Dscam
isoforms at the level of translation (e.g., by microRNA) should
deplete the isoforms of interest without affecting the expression
of others. This way, one can potentially map the endogenous
patterns of expression for various specific subsets of Dscam iso-
forms and, more importantly, unequivocally determine the con-
tributions made by given subsets of Dscam isoforms to various
neural developments. In the case of Dscam[TM1] versus
Dscam[TM2], we found that, although the relative abundance
might differ at various developmental stages, they are apparently
coexpressed in most cells. The coexpression with differential re-
quirements implies that they are functionally distinct.
Dscam[TM1] selectively concentrates in dendritic growth cones,
whereas Dscam[TM2] is preferentially located to axonal growth
cones. Nevertheless, we could not observe their differential tar-
geting after depletion of one versus the other, because most neu-
ropils are made up of both dendrites and axons. We also recently
learned that retrograde transport plays an essential role in the
dendritic enrichment ofDscam[TM1] (our unpublished results),
Figure4. Rescue ofDscammutant PNmorphogenesis by transgenic Dscamwith TM1versus TM2.A–H, Adult single-cell clones
of DL-1 PNs (green) of which the dendrite elaboration in the DL-1 glomeruli (as revealed by nc82 immunostaining; magenta) and
axon arborization in the MB calyces and the LHs are, respectively, shown in A–D and E–H. A, E, Wild-type clones. B, F, Dscam
mutant clones. C, G, Rescue of mutant clones with pDscam-Dscam[3.36.25.1-genomic 18–24]. D, H, Rescue with pDscam-
Dscam[3.36.25.2-genomic 18–24]. Note partial coverage of DL-1 glomeruli by the green PN dendrites inB andD and the absence
of bouton-like structures (arrowheads) in F and G. I–J, Quantitative analysis of the coverage of DL-1 glomeruli by single-cell PN
clones (I ) and the numbers of PN-derived bouton-like structures in the MB calyces (J ). n 25 in every condition.
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potentially explaining why both Dscam[TM1] andDscam[TM2]
could be detected in the cores of larval MB peduncles where
newly derived MB axons are selectively fasciculated (our unpub-
lished observation). Finally, compared with the constitutive
changes associated with gene targeting, GAL4/UAS-mediated
targeted induction of RNAi permits more varied control over
when and/or where to knock down the isoforms of interest and
should better illustrate the stage- as well as tissue-specific
isoform-characteristic functions.
Together, our results indicate Dscams with distinct TMs are
differentially involved in morphogenesis of dendrites versus ax-
ons, most likely because of differential protein targeting. What
might be the advantages for having two exon alternatives to spec-
ify where a Dscam protein should be located? One possible ad-
vantage is the ability to independently control the Dscam reper-
toire at dendrite and axon within a single neuron. For instance,
coupling different ectodomains with TM1would permit selective
enrichment of Dscams with distinct homophilic binding speci-
ficities in the dendrites but not axons. Additionally, for a given
ectodomain, varying the ratio of TM1/TM2 could simulta-
neously alter the amounts of dendritic and axonal Dscams. Given
that dendrites and axons of the same neurons often acquire dif-
ferentmorphological characteristic features, it would be interest-
ing to determine whether the TM1/TM2-governed differential
distribution of Dscam directly underlies some aspects of the dif-
ferential morphogenesis of dendrites versus axons.
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